Solara Active Pharma Sciences Ltd. (SOLARA): SOLARA 52 Week High Streak: Second Straight Session After Fresh Peak
- September 11, 2026
- Posted by: Harsh Piplani
- Category: News
SOLARA has now set a fresh 52-week high for its second straight session, and the streak has moved 8.48% from the start of this run. The latest peak is Rs 759.95, while the stock last traded at Rs 748.5. According to latest Univest data, the price pattern is confirmed, but no company-specific catalyst is established by the market data alone.
As of 11 September 2026 at 3:22 PM IST, SOLARA last traded above its previous close of Rs 707.85 after opening at Rs 700.85 and touching a low of Rs 697 during the session. Turnover stood at Rs 6.4 crore and market capitalisation at Rs 3,329.29 crore. For readers, this repeated 52-week high streak says more than a one-day breakout: it shows the stock has continued to reset its yearly benchmark across consecutive sessions.
SOLARA 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 748.5 |
| Previous Close | Rs 707.85 |
| Today's Move | +Rs 40.65 (+5.74%) |
| Open | Rs 700.85 |
| High | Rs 759.95 |
| Low | Rs 697 |
| Turnover | Rs 6.4 crore |
| Market Capitalisation | Rs 3,329.29 crore |
Solara Active Pharma Sciences Ltd. (SOLARA) traded at Rs 748.5 versus the previous close of Rs 707.85, a rise of 5.74%. The stock opened at Rs 700.85, reached a high of Rs 759.95 and touched a low of Rs 697.
SOLARA last traded at Rs 748.5, up Rs 40.65 or 5.74% from the previous close of Rs 707.85. The stock opened at Rs 700.85, which was below the previous close, then moved to a high of Rs 759.95 and a low of Rs 697. The day’s high matched the fresh 52-week peak, so the latest reading sits near the upper end of the observed range.
Turnover was Rs 6.4 crore, while market capitalisation stood at Rs 3,329.29 crore. For a stock in a repeated one-year high sequence, this session matters because it adds another data point to the streak rather than standing alone as a single breakout. The current price is also above the previous close by a clear margin, which keeps the stock in the market’s daily stock news flow and the broader “Stocks Hitting 52 Week Highs” conversation.
What the Repeated 52-Week Highs Show
SOLARA 52 Week High Streak now covers a second straight session, and the cumulative move across the run is 8.48%. That is the clearest differentiator from a one-day breakout. The first breakout on 10 September 2026 established the trend, and the latest session extended it by taking the stock to another fresh yearly high. The current 52-week high of Rs 759.95 is the same level recorded in the latest session, so the streak is being marked by price repetition at the top rather than a retreat from it.
What the repeated highs show is simple: the market has continued to reprice the stock within the 52-week window across back-to-back sessions. The data confirms the pattern, but it does not establish why the move has persisted. For readers tracking SOLARA share price today, the more useful question is not whether the stock broke out once, but whether this consecutive pattern can continue to hold above earlier trading levels without a fresh adverse shift in price behaviour.
Solara Active Pharma Sciences Ltd. (SOLARA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,329.29 crore |
| P/B Ratio | 2.69x |
| ROE | -0.63% |
| ROCE | 4.61% |
| EPS | Rs -0.34 |
| Book Value Per Share | Rs 263.29 |
| Dividend Yield | 0% |
Solara Active Pharma Sciences Ltd. (SOLARA) fundamental metrics show P/B 2.69x, ROE -0.63%, ROCE 4.61%. These figures provide context only and are not a buy or sell signal.
Solara Active Pharma Sciences Ltd. has a market capitalisation of Rs 3329.29 crore, which gives readers a sense of company size before judging valuation. On valuation, P/B at 2.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -0.63% and ROCE of 4.61%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -0.34, book value per share of Rs 263.29, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.87%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.1x |
| Benchmark P/E Range | 3.4x to 701.57x |
| Company P/B Ratio | 2.69x |
| Benchmark Median P/B | 3.09x |
| Company ROE | -0.63% |
| Benchmark Median ROE | 11.87% |
| Company ROCE | 4.61% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 3,329.29 crore |
| Benchmark Median Market Cap | Rs 715.37 crore |
Solara Active Pharma Sciences Ltd. (SOLARA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Solara Active Pharma Sciences Ltd. (SOLARA) has a ROE of -0.63%, which is below the benchmark median of 11.87%, a difference of -105.31%. Solara Active Pharma Sciences Ltd. (SOLARA) has a ROCE of 4.61%, which is below the benchmark median of 13.71%, a difference of -66.37%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 3,353.69 | 20.46 | 2.04 | 11.43 | 15.27 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 3,375.85 | 57.27 | 2.2 | 24.68 | 24.24 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,714.52 | 44.99 | 10.23 | 22.67 | 24.01 |
| SMS Pharmaceuticals Ltd. | SMSPHARMA | 3,815.38 | 38.33 | 4.87 | 11.91 | 12.55 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,819.16 | 12.31 | 1.36 | 9.81 | 10.68 |
Its ROE of -0.63% compares with a peer median of 11.91% across the companies shown in the table. ROCE stood at 4.61% versus the displayed peer median of 15.27%, providing a capital-efficiency comparison. Solara Active Pharma Sciences Ltd. (SOLARA) has a market capitalisation of Rs 3,329.29 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching SOLARA
- SOLARA has set a fresh 52-week high for a second straight session.
- The cumulative streak move is 8.48%, which separates this from a single-day breakout.
- The latest peak of Rs 759.95 marks the current yearly high level.
- Market capitalisation stands at Rs 3,329.29 crore, keeping valuation in focus.
- ROE, ROCE and EPS remain important to monitor alongside the stock news flow.
About Solara Active Pharma Sciences Ltd.
Solara Active Pharma Sciences Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector and is listed on NSE and BSE as SOLARA. The company’s current market capitalisation is Rs 3,329.29 crore, and its latest read shows a price-to-book ratio of 2.69, book value of Rs 263.29 and EPS of -0.34. The company’s return metrics remain uneven, with ROE at -0.63% and ROCE at 4.61%.
For readers tracking SOLARA stock performance, this combination of a repeated 52-week high streak and mixed fundamentals is the key setup to watch. The market is signalling strength through price, while the financial ratios suggest the broader company analysis should still stay grounded in valuation and earnings context rather than only in the one-year high headline.
Track SOLARA on Univest
Track SOLARA on Univest for live stock news, market cap updates, company financials and the latest share price update. Use the platform to monitor how the 52-week high streak develops alongside sector analysis, peer comparison and future stock performance. The current setup keeps SOLARA in focus for readers following stocks at one year high today.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is SOLARA still hitting 52-week highs?
Ans. SOLARA has now set a fresh 52-week high for a second straight session, which confirms a repeated price pattern. The market data shows the streak, but it does not establish a company-specific catalyst for the continued move.
What is the SOLARA 52 Week High Streak right now?
Ans. The current SOLARA 52 Week High Streak is the second straight session. The stock has made a fresh yearly high on each of those sessions, and the cumulative move across the streak is 8.48%.
What is the latest 52-week high for SOLARA?
Ans. SOLARA’s latest 52-week high is Rs 759.95. That level was touched in the latest session and marks the current one-year peak in the ongoing streak. The stock moved 5.74% so far today.
How did SOLARA trade during the session?
Ans. SOLARA last traded at Rs 748.5 after opening at Rs 700.85 and touching a low of Rs 697. The stock moved up to Rs 759.95 during the session, while turnover stood at Rs 6.4 crore.
How does SOLARA compare with its previous close?
Ans. The stock was up Rs 40.65, or 5.74%, versus the previous close of Rs 707.85. That price change came alongside a fresh one-year high and kept the share price in focus.
Is SOLARA expensive compared with its sector?
Ans. SOLARA’s price-to-book ratio of 2.69 is below the sector median of 3.09 for the comparable healthcare set. On the data provided, that makes it less expensive on P/B than the typical peer median, while profitability remains mixed.
What fundamental numbers should investors watch next?
Ans. Investors are likely to track ROE, ROCE, EPS, book value and future revenue trends. SOLARA’s current ROE is -0.63%, ROCE is 4.61%, EPS is -0.34 and book value is Rs 263.29.
What should investors monitor after back-to-back 52-week highs?
Ans. Readers should watch whether SOLARA continues to register fresh yearly highs, how the stock trades relative to the previous close, and whether the streak is supported by improving financial metrics. The repeated high pattern is confirmed; the reason for it is not.
Track Solara Active Pharma Sciences Ltd. (SOLARA) Share Price on Univest
Use Solara Active Pharma Sciences Ltd. (SOLARA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
